Specified Drug Use-results Survey of Betanis Tablets

Astellas

Status: Completed

Conditions: Overactive Bladder

Treatments: Drug: mirabegron

Study type: Observational

Funder types: Industry

Identifiers

NCT01898624

BE0004

Details and patient eligibility

About

To investigate the effects of mirabegron on the symptoms of glaucoma in overactive bladder (OAB) patients with coexisting glaucoma.

Enrollment: 300 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• diagnosed as OAB and treated with mirabegron
• diagnosed as glaucoma (including normal tension glaucoma)
• having intraocular pressure measurement conducted more than twice within six months before the start of the mirabegron treatment

Trial design

300 participants in 1 patient group

Betanis group

Description:

mirabegron treated group

Treatment:

Drug: mirabegron